[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334727-105":59,"doc-detail-334727-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","kif3c-an-emerging-biomarker-with-prognostic-and-immune-implications-across-pan-cancer-types-and-its-experiment-validation-in-gastric-cancer","KIF3C - an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer","","Kinesin Family Member 3C (KIF3C) plays key roles in multiple biological processes in human cancers, yet comprehensive assessments of its contribution across malignancies remain limited. An extensive analysis evaluates KIF3C expression, prognostic value, molecular functions, tumor immunity, and drug sensitivity, supported by functional enrichment results and in vitro gastric cancer experiments. KIF3C is elevated across tumors versus normal tissues, predicts poorer OS, DSS, and PFS, links with pathological stages, and correlates with immune-cell infiltration. KIF3C affects PI3K/AKT signaling, shows associations with anti-cancer IC50 values, and KIF3C knockdown suppresses proliferation, migration, invasion, and alters apoptosis and cell cycle, suggesting therapeutic potential in gastric cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kif3c-an-emerging-biomarker-with-prognostic-and-immune-implications-across-pan-cancer-types-and-its-experiment-validation-in-gastric-cancer/334727/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kif3c-an-emerging-biomarker-with-prognostic-and-immune-implications-across-pan-cancer-types-and-its-experiment-validation-in-gastric-cancer/334727.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is KIF3C, and why is it studied in cancers?","Question",{"text":112,"@type":113},"KIF3C is a kinesin motor protein involved in multiple cellular processes. It has accumulating evidence supporting a regulatory role in cancer, prompting investigation across malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does KIF3C expression relate to patient prognosis?",{"text":117,"@type":113},"Higher KIF3C expression is associated with unfavorable clinical outcomes, including reduced OS, DSS, and PFS across several cancer types, and it correlates with pathological stages.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental findings support KIF3C’s role in gastric cancer?",{"text":121,"@type":113},"In gastric cancer cells, KIF3C knockdown reduces proliferation, migration, and invasion, increases apoptosis, and alters the cell cycle. The analysis also links KIF3C to the PI3K/AKT signaling pathway and drug sensitivity patterns.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334727,1790033801,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 7  \nResearch Paper  \nKIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer  \nQiangqiang Zhong1,2, Wenbo Hong1,2, Lina Xiong1  \n1 Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430077, China  \n2 Laboratory of Metabolic Abnormalities and Vascular Aging Huazhong University of Science and Technology, Wuhan 430077, China  \nCorrespondence to: Lina Xiong; email: [xionglina1978@163.com](xionglina1978@163.com), [https://orcid.org/0009-0005-8191-6452](https://orcid.org/0009-0005-8191-6452)[ ](https://orcid.org/0009-0005-8191-6452)[Keywords:](Keywords: KIF3C)[ KIF3C](Keywords: KIF3C), pan-cancer, gastric cancer, biomarker, prognosis  \nReceived: November 16, 2023 Accepted: February 8, 2024 Published: March 28, 2024  \nCopyright: © 2024 Zhong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nKinesin Family Member 3C (KIF3C) assumes a crucial role in various biological processes of specific human cancers. Nevertheless, there exists a paucity of systematic assessments pertaining to the contribution of KIF3Cin human malignancies. We conducted an extensive analysis of KIF3C, covering its expression profile, prognostic relevance, molecular function, tumor immunity, and drug sensitivity. Functional enrichment analysis was also carried out. In addition, we conducted in vitro experiments to substantiate the role of KIF3C in gastric cancer (GC) . KIF3C expression demonstrated consistent elevation in various tumors compared to their corresponding normal tissues. We further unveiled that heightened KIF3C expression served as a prognostic indicator, and its elevated levels correlated with unfavorable clinical outcomes, encompassing reduced OS, DSS, and PFS in several cancer types. Notably, KIF3C expression exhibited positive associations with the pathological stages of several cancers. Moreover, KIF3C demonstrated varying relationships with the infiltration of various distinct immune cell types in gastric cancer. Functional analysis outcomes indicated that KIF3C played a role in the PI3KAKT signaling pathway. Drug sensitivity unveiled a positive relationship between KIF3C in gastric cancer and the IC50 values of the majority of identified anti-cancer drugs. Additionally, KIF3C knockdown reduced the proliferation, migration, and invasion capabilities, increased apoptosis, and led to alterations in the cell cycle of gastric cancer cells. Our research has revealed the significant and functional role of KIF3C as a tumorigenic gene in diverse cancer types. These findings indicate that KIF3C may serve as a promising target for the treatment of gastric cancer.  \nINTRODUCTION  \nGastric cancer (GC) has emerged as the fourth most prevalent malignant tumor globally, according to [1] . Unfortunately, a substantial number of GC patients receive their diagnosis in the advanced stages of the disease, resulting in a significant number of cancerrelated fatalities. More than half of all gastric cancer cases are reported in developing nations, particularly in high-incidence regions such as East Asia and South  \nAmerica [2] . Gastric cancer is characterized by its insidious onset, rapid progression, and a propensity for postoperative recurrence, rendering it one of the most pressing public health challenges in China. The limited rate of early diagnosis in gastric cancer is attributed not only to its high invasiveness but also to the absence of specific biomarkers for early detection. In light of this situation, numerous researchers are actively investigating novel diagnostic markers and potential therapeutic targets for this disease. ","cbCaiaeKKiNEFaal","https://ap.wps.com/l/cbCaiaeKKiNEFaal","pdf",6082302,25,"English","# Abstract\n# Introduction\n## Gastric cancer burden and need for biomarkers\n## Kinesin proteins and kinesin-2 subfamily\n## Functions of KIF3C in cellular processes and cancer background","[{\"question\":\"What is KIF3C, and why is it studied in cancers?\",\"answer\":\"KIF3C is a kinesin motor protein involved in multiple cellular processes. It has accumulating evidence supporting a regulatory role in cancer, prompting investigation across malignancies.\"},{\"question\":\"How does KIF3C expression relate to patient prognosis?\",\"answer\":\"Higher KIF3C expression is associated with unfavorable clinical outcomes, including reduced OS, DSS, and PFS across several cancer types, and it correlates with pathological stages.\"},{\"question\":\"What experimental findings support KIF3C’s role in gastric cancer?\",\"answer\":\"In gastric cancer cells, KIF3C knockdown reduces proliferation, migration, and invasion, increases apoptosis, and alters the cell cycle. The analysis also links KIF3C to the PI3K/AKT signaling pathway and drug sensitivity patterns.\"}]","KIF3C - an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer | PDF",1790008048,63]